Marc Lohrmann
InvestorManaging Partner Fund 3 at Vesalius Biocapital III Partners SàRL
Greater Munich Metropolitan Area
Find your path to Marc
35 people in our graph share verified history with Marc — schools, employers, funds. One of them is your warm intro.
Alexander StoeckelunlockedMarc: together at SOFTHALE NV (2019–2021)
×2Marc: together at CatalYm
Marc: together at Topas Therapeutics
Marc: together at Vesalius Biocapital
About
Joined Vesalius Biocapital in 2012 as venture partner and became Managing Partner for Fund 3 in 2017. Co-founded several life sciences companies including Reverse Medical and Softhale, and previously worked at Bayer Innovation and in life sciences M&A.
Contact· self-published, not guessed
Experience
- DIOSCURI BIOPHARMACEUTICALSCo-Founder / Managing Directorcurrent2024 — present
- CatalYm GmbHBoard Observercurrent2024 — present
- CatalYm GmbHBoard of Directors2020 — 2024Munich, Bavaria, Germany
- MIGRAINYCo-Founder / Managing Directorcurrent2022 — present
- EyeNebCo-Founder / Managing Directorcurrent2022 — present
- Topas Therapeutics GmbHBoard of Directorscurrent2020 — presentHamburg, Germany
- DEARhealthBoard of Directorscurrent2019 — presentAmsterdam, North Holland, Netherlands
- Vesalius BiocapitalManaging Partner Vesalius Biocapital IIIcurrent2017 — presentLuxemburg and Munich
- Vesalius BiocapitalVenture Partner2012 — 2017Munich
- KELESInvestment Partner2025
- PEDIATRICS CAPITALCo-Founder / Managing Partner2022 — 2025
- SOFTHALE NVFounder2014 — 2021Hasselt
- Reverse MedicalFounder2007 — 2014Irvine, CA
- JSB-Partners, LPSenior Advisor2011 — 2013
- Mummert & CompanyAssociate Partner2008 — 2011
- Proventis Partners GmbHAssociate Partner2007 — 2008Munich
- Bayer InnovationInvestment Manager2003 — 2007Duesseldorf
- Nimbus BiotechnologieHead of Business Development2003Greater Leipzig Area
- m-phasysChief Business Officer1999 — 2003Tuebingen
Skills & more
Start-ups27Risikokapital6Strategisches Management11Unternehmensstrategie21Fusionen und Übernahmen3Risikoprüfung2Unternehmertum8Unternehmensentwicklung5Privates Eigenkapital18Biowissenschaften1
From Marc's professional profile.
Colleagues at Vesalius Biocapital III Partners SàRL
Cees Wortel
Venture Partner Fund 3 at Vesalius Biocapital III Partners SàRL
Christian Schneider
Managing Partner at Vesalius Biocapital III Partners SàRL
David Braga Malta
Venture Partner Fund 3 at Vesalius Biocapital III Partners SàRL
Fabienne Roussel
Analyst at Vesalius Biocapital III Partners SàRL
Guy Geldhof
Managing Partner at Vesalius Biocapital III Partners SàRL
Judith Murazishya
Management Assistant at Vesalius Biocapital III Partners SàRL
Martine Goossens
Management Assistant at Vesalius Biocapital III Partners SàRL
Pauki Tran
Controller at Vesalius Biocapital III Partners SàRL
Frequently asked questions
- Who is Marc Lohrmann?
- Joined Vesalius Biocapital in 2012 as venture partner and became Managing Partner for Fund 3 in 2017. Co-founded several life sciences companies including Reverse Medical and Softhale, and previously worked at Bayer Innovation and in life sciences M&A.
- Where does Marc Lohrmann work?
- Marc Lohrmann is Managing Partner Fund 3 at Vesalius Biocapital III Partners SàRL.
- Where did Marc Lohrmann go to school?
- Marc Lohrmann studied at University of Stuttgart-Hohenheim (Diplom-Oekonom, Business Administration).
Shared employers
Also worked at CatalYm GmbH11
Marianne UtengManaging Director at Novartis Venture FundDaniela CoutoGeneral Partner at BioGeneration VenturesPascal TouchonOperating Partner at Jeito CapitalHelmsManaging Director & Chief Financial Officer at Longitude CapitalJon EdwardsGeneral Partner at ForbionJasper BosGeneral Partner at Forbion
+ 5 more


























